Perigon Wealth Management LLC Sells 4,140 Shares of Aflac Incorporated (NYSE:AFL)

Perigon Wealth Management LLC cut its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 37.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,978 shares of the financial services provider's stock after selling 4,140 shares during the period. Perigon Wealth Management LLC's holdings in Aflac were worth $776,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Whipplewood Advisors LLC acquired a new stake in Aflac in the fourth quarter valued at approximately $26,000. Garde Capital Inc. acquired a new stake in Aflac in the first quarter valued at approximately $36,000. Curio Wealth LLC acquired a new stake in Aflac in the fourth quarter valued at approximately $36,000. Capital A Wealth Management LLC acquired a new stake in Aflac in the fourth quarter valued at approximately $38,000. Finally, OFI Invest Asset Management acquired a new stake in Aflac in the fourth quarter valued at approximately $38,000. 67.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Masatoshi Koide sold 37,000 shares of the firm's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the transaction, the director now owns 70,992 shares of the company's stock, valued at $7,496,045.28. This trade represents a 34.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of Aflac stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total transaction of $290,675.00. Following the completion of the transaction, the director now directly owns 6,728 shares of the company's stock, valued at $711,149.60. The trade was a 29.01% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 40,750 shares of company stock valued at $4,304,295 over the last 90 days. Insiders own 0.90% of the company's stock.

Aflac Trading Up 1.2%

Shares of Aflac stock opened at $105.12 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09. The firm has a fifty day moving average price of $104.55 and a 200 day moving average price of $105.20. Aflac Incorporated has a 1 year low of $88.00 and a 1 year high of $115.50. The stock has a market cap of $56.83 billion, a PE ratio of 16.43, a price-to-earnings-growth ratio of 3.25 and a beta of 0.82.

Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a return on equity of 15.55% and a net margin of 21.27%. The business had revenue of $3.40 billion for the quarter, compared to analysts' expectations of $4.53 billion. During the same period last year, the business earned $1.66 EPS. The company's revenue for the quarter was down 37.5% on a year-over-year basis. Equities research analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were issued a dividend of $0.58 per share. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 annualized dividend and a dividend yield of 2.21%. Aflac's dividend payout ratio (DPR) is presently 36.25%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on AFL shares. Barclays raised their target price on shares of Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a research note on Thursday, May 1st. Piper Sandler raised their target price on shares of Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Wall Street Zen downgraded shares of Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Wells Fargo & Company raised their price target on shares of Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 6th. Finally, UBS Group raised their price target on shares of Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $106.50.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.